MAPT and Alzheimer disease: PET (Positron Emission Tomography): Even in the preclinical phases of Alzheimer's disease, pathological markers of the disease can be seen in the brain by using PET imaging using radiotracers that target tau and amyloid-beta protein clumps [123].